Table 1.
Patients’ clinical characteristics
| Mean ± SD (median) | Range | |
|---|---|---|
| Age (years) |
70.2 ± 8.4 (72) |
45 – 89 |
| PSA (ng/mL) |
1,029 ± 1,896 (260) |
2.4 – 12,490 |
| HGB (g/dL) |
13.1 ± 1.9 (13.3) |
7.4 – 17.4 |
| ALP (IU/L) |
615 ± 908 (291) |
50 – 5,870 |
| LDH (IU/L) |
295 ± 180 (222) |
97 – 1,273 |
| Follow-up (months) |
46.4 ± 36.1 (37) |
1 – 209 |
| |
N (%) |
|
| Metastases |
|
|
| Bone only |
106 (49.3) |
|
| Lymph nodes |
98 (45.6) |
|
| Other organs |
15 (7.0) |
|
| Gleason score |
|
|
| < 7 |
15 (7.0) |
|
| 7 – 8 |
81 (37.7) |
|
| 9 – 10 |
109 (50.7) |
|
| Unknown | 10 (4.6) |